Four recent published studies highlight important research by Roswell Park Comprehensive Cancer Center scientists in several types of cancers. They range from new insights on effective treatment decision-making for patients with rectal cancer to new strategies for improving outcomes or reducing side effects for patients with prostate cancer, pancreatic cancer and melanoma.

Western New York healthcare and medical research leaders are joining forces in an effort to uncover hidden information from the cells of those who have been exposed to the novel coronavirus, seeking insights on how best to care for those who develop COVID-19 illness.

A new analysis led by physicians at Roswell Park Comprehensive Cancer Center, published in JAMA Network Open, shows that some patients with small node-negative breast tumors that test positive for both the hormone receptor (HR) and ERBB2, also known as HER2/neu, proteins could benefit from chemotherapy in addition to surgery, radiation and endocrine therapy.

While it has long been thought that locally-delivered radiation therapy typically does not help to shrink tumors outside the field of irradiation, new preclinical research from a team at Roswell Park Comprehensive Cancer Center suggests a strategy for significantly increasing both the local and distant, or “abscopal,” effects of radiation.

Our patients and their loved ones have many questions about cancer care during the COVID-19 pandemic. Every Friday, our experts will host webinars to help provide answers on a variety of topics.